Huntington's DiseaseNCT01574053
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
An observational study of Huntington's Disease, run by CHDI Foundation, Inc. at 183 sites in 20 countries.
Trial summary
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Huntington's Disease
- How many people
- 35,000 participants
- Where
- 183 sitesin 20 countries
- Study dates
- Jul 2012to Jan 2062
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients with HD and their family members are recruited from specialty clinics (Human Genetics, Neurology, Psychiatry) that advise and treat people affected by HD. In addition, in some areas community clinics and neurologists who see HD patients recruit participants for this study. Participants also receive information about the study through websites, clinical practices, support groups, advocacy newsletters, etc. and place a direct request to be considered for participation in the study. Community controls are identified by study site staff (using advertisements, flyers and newsletters) with the support of the Enroll-HD operational staff.
Who may be able to join
- Carriers: This group comprises the primary study population and consists of individuals who carry the HD gene expansion mutation.
- Controls: This group comprises the comparator study population and consists of individuals who do not carry the HD expansion mutation.
- These two major categories can be further subdivided into six different subgroups of eligible individuals:
- Manifest/Motor-manifest HD: Carriers with clinical features that are regarded in the opinion of the investigator as diagnostic of HD.
- Pre-Manifest/-Motor-manifest HD: Carriers without clinical features regarded as diagnostic of HD.
- Genotype Unknown: This group includes a first or second degree relative (i.e., related by blood to a carrier) who has not undergone predictive testing for HD and therefore has an undetermined carrier status.
Show all 10Show fewer
- Genotype Negative: This group includes a first or second degree relative (i.e., related by blood to a carrier) who has undergone predictive testing for HD and is known not to carry the HD expansion mutation.
- Family Control: Family members or individuals not related by blood to carriers (e.g., spouses, partners, caregivers).
- Community Controls: Individuals unrelated to HD carriers who did not grow up in a family affected by HD. Data collected from community controls will be used for generation of normative data for sub-studies.
- Participant status will be captured in the study database using 2 variables: 1) Investigator Determined Status: this will be based on clinical signs and symptoms and genotyping performed as part of medical care, and will be updated at every visit; and 2) Research Genotyping Status: this will be based on genotyping conducted as part of Enroll-HD study procedures. Based on research genotyping, participants will be reclassified under this variable from Genotype Unknown to 'Carriers' or 'Controls'. Investigators and participants will be blinded to this reclassification.
Who cannot join
- Individuals who do not meet inclusion criteria,
- Individuals with choreic movement disorders in the context of a negative test for the HD gene mutation.
- For Community Controls: those individuals with a major central nervous system disorder will be excluded (e.g. stroke, Parkinson's disease, multiple sclerosis, etc.).
- Participants under 18 may be eligible to participate (if they have juvenile-onset HD).
Trial locations and contacts
183 sites in 20 countries. Contact the study team or a site near you to ask about taking part.
Noopur Modi contact
183 sites in 20 countries
United States62 sites, 52 recruiting
- Recruiting
Albany Medical College
Albany, New York, 12208
Alicia Leader, 518-262-6682, downeya@amc.edu
Era Hanspal
- Recruiting
University of Michigan
Ann Arbor, Michigan, 48105
Chris Graves, 734-764-0644, gravesch@med.umich.edu
Noelle Carlozzi
- Recruiting
Emory University, Wesley Woods Health Center
Atlanta, Georgia, 30329
Elaine Sperin, 404-712-7044, esperin@emory.edu
Stewart Factor
- Terminated
Georgia Health Sciences University
Augusta, Georgia, 30912
- Withdrawn
University of Maryland School of Medicine
Baltimore, Maryland, 21201
- Recruiting
Johns Hopkins University
Baltimore, Maryland, 21287
Etta Goldman, 410-614-9483, egoldm17@jhmi.edu
Jee Bang
- Recruiting
University of Alabama
Birmingham, Alabama, 35294
Jenna Smith, 205-996-2807, jltidwell@uabmc.edu
Victor Sung
- Terminated
Boston University Medical Center
Boston, Massachusetts, 02118
- Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
Sophia Antonioli, 617-667-2355, santoni1@bidmc.harvard.edu
Samuel Frank
- Recruiting
University of Vermont
Burlington, Vermont, 05401
Jasmine Marsh, 802-847-1597, jasmine.marsh@uvmhealth.org
James Boyd
- Active, not recruiting
Cooper University Hospital
Camden, New Jersey, 08103
- Recruiting
University of Virginia
Charlottesville, Virginia, 22908
Lauren Miller, 434-982-6599, fdk5dn@virginia.edu
Alex Dalrymple
- Recruiting
Northwestern University
Chicago, Illinois, 60611
Zsa Zsa Brown, 312-503-4121, zsazsa.brown@northwestern.edu
Danny Bega
- Terminated
University of Chicago
Chicago, Illinois, 60637
- Recruiting
Rush University Medical Center
Chicago, Illinois, 68612
Tyler Svymbersky, 312-563-0676, tyler_svymbersky@rush.edu
Deborah A. Hall
- Recruiting
University of Cincinatti
Cincinnati, Ohio, 42519
Bobbie Stubbeman, 513-558-0142, stubbebl@ucmail.uc.edu
Andrew Duker
- Recruiting
Cleveland Clinic
Cleveland, Ohio, 44195
Courtney Cannon, 216-445-5637, cannonc2@ccf.org
Adam Margolius
- Recruiting
University of South Carolina
Columbia, South Carolina, 29203
Michael Parrish, 803-545-6103, michael.parrish@prismahealth.org
Miroslav Cuturic
- Recruiting
The Ohio State University
Columbus, Ohio, 43021
Kaleigh Clevenger, 614-257-2784, kaleigh.clevenger@osumc.edu
Sandra Kostyk
- Withdrawn
Wayne State University
Detroit, Michigan, 48201
- Recruiting
Duke University
Durham, North Carolina, 27705
Michelle Moshkowitz, 919-664-0865, michelle.moshkowitz@duke.edu
Burton Scott
- Recruiting
Cenexel Rocky Mountain Clinical Research, LLC
Englewood, Colorado, 80113
Liza Heap, 303-762-6674, e.heap@cenexel.com
Rajeev Kumar
- Recruiting
Sanford Health
Fargo, North Dakota, 58122
Destini Spaeth, 701-234-2474, destini.spaeth@sanfordhealth.org
Tanya Harlow
- Recruiting
University of Connecticut
Farmington, Connecticut, 06032
Robin Zingales-Browne, 860-679-4418, rbrowne@uchc.edu
Shaikab Khan
- Recruiting
University of Florida Board of Trustees
Gainesville, Florida, 32607
Randy Foli, 352-733-2433, randy.foli@neurology.ufl.edu
Nikolaus McFarland
- Recruiting
Virginia Commonwealth University Parkinson's and Movement Disorders Center
Henrico, Virginia, 23298
Kara McHaney, 804-628-1809, kara.mchaney@vcuhealth.org
Stephanie Bissonnette
- Recruiting
Baylor College of Medicine
Houston, Texas, 77030
Clarissa Sanchez, 713-798-5120, clarissa.sanchez@bcm.edu
Joseph Jankovic
- Recruiting
University of Texas Health Science Center
Houston, Texas, 77030
Brittany Duncan, 713-486-3134, brittany.j.duncan@uth.tmc.edu
Erin Furr Stimming
- Recruiting
Indiana University
Indianapolis, Indiana, 46202
Courtney Gatza, 317-274-9657, cgatza@iupui.edu
Christopher James
- Recruiting
University of Iowa
Iowa City, Iowa, 52245
Julie Koeppel, 319-353-4551, julie-koeppel@uiowa.edu
Annie Killoran
- Recruiting
University of California - Irvine Medical Center
Irvine, California, 92697
Veronica Martin, 714-456-7760, vero@hs.uci.edu
Anna Morenkova
- Recruiting
University of Kansas Medical Center
Kansas City, Kansas, 66160
Cameron Zoraghchi, 913-588-0667, czoraghchi2@kumc.edu
Richard Dubinksy
- Recruiting
Booth Gardner Parkinson's Care Center (Evergreen Health)
Kirkland, Washington, 98034
Anthony Sander, 425-899-5416, agsader@evergreenhealthcare.org
Pinky Argarwal
- Recruiting
Cleveland Clinic - Las Vegas
Las Vegas, Nevada, 89102
Liliana Dumitrescu, 702-483-6016, dumitrl@ccf.org
Zoltan Mari
- Terminated
Loma Linda Medical Center
Loma Linda, California, 92354
- Recruiting
University of California - Los Angeles
Los Angeles, California, 90095
Aaron Fisher, 310-794-1225, adfisher@mednet.ucla.edu
Susan Perlman
- Recruiting
University of Louisville
Louisville, Kentucky, 40202
Annette Robinson, 502-540-3585, annette.robinson@louisville.edu
Victoria Holiday
- Recruiting
University of Wisconsin - Madison
Madison, Wisconsin, 53705
Kim Janko, 608-262-8027, janko@neurology.wisc.edu
Kathleen Shannon, MD
- Terminated
University of Tennessee Health Science Center
Memphis, Tennessee, 38163
- Recruiting
University of Miami
Miami, Florida, 33431
Wilfredo Rodriguez Somoza, 561-939-4169, wxr205@med.miami.edu
Carlos Singer
- Recruiting
Hennepin County Medical Center
Minneapolis, Minnesota, 55415
Dawn Radtke, 612-873-2943, dawn.radtke@hcmed.org
Martha Nance
- Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, 37232
Elizabeth Huitz, 615-936-1007, elizabeth.huitz@vumc.org
Daniel Claassen
- Recruiting
Rutgers, the State University of New Jersey
New Brunswick, New Jersey, 08901
Sheila Redding, 732-235-7718, sr1238@rwjms.rutgers.edu
Machteld Hillen
- Recruiting
Columbia University
New York, New York, 10032
Paula Wasserman, 212-305-4597, pl2032@cumc.columbia.edu
Karen Marder
- Recruiting
University of Nebraska Medical Center
Omaha, Nebraska, 68106
Nick Miller, 402-552-6241, nicholas.miller@unmc.edu
Amy Hellman
- Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, 19107
Jennifer Klapper, 215-829-5176, jennifer.klapper@pennmedicine.upenn.edu
Aaron Lasker
- Recruiting
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013
Aleksander Gomez, 602-406-3719, aleksander.gomez@commonspirit.org
Nicki Niemann
- Recruiting
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213
Patricia Conlon, 412-692-2394, patricia.conlon@pitt.edu
Valerie Suski
- Recruiting
Oregon Health and Science University
Portland, Oregon, 97239
Emily Leonard, 503-367-4719, leonarde@ohsu.edu
Amie Hiller, MD
- Active, not recruiting
Virginia Commonwealth University
Richmond, Virginia, 23233
- Recruiting
University of Rochester
Rochester, New York, 14618
Hannah Mesmer, 585-341-7500, hannah_mesmer@urmc.rochester.edu
Frederick Marshall
- Terminated
University of Illinois College of Medicine at Rockford
Rockford, Illinois, 61107
- Recruiting
University of California - Davis
Sacramento, California, 95817
Rajwant Singh, 916-734-6278, rajsin@ucdavis.edu
Talia Hamm, (916) 734-3541, tghamm@ucdavis.edu
- Recruiting
University of Utah
Salt Lake City, Utah, 84108
Paola Wall, 801-581-4543, paola.wall@hsc.utah.edu
Paolo Moretti
- Recruiting
University of California - San Diego
San Diego, California, 92037
Sean Patel, 858-249-0568, svp004@health.ucsd.edu
Jody Corey-Bloom
- Recruiting
University of California - San Francisco
San Francisco, California, 94158
Zach Lamson, 415-502-0670, zach.lamson@ucsf.edu
Michael Geschwind
- Recruiting
University of Washington Medical Center
Seattle, Washington, 98195
Amy Good, 206-543-5933, amygood@uw.edu
Debra Castillo, 206-543-3647, debradel@uw.edu
- Recruiting
Washington University in St. Louis
St Louis, Missouri, 63110
Stacey Barton, 314-362-3471, bartons@neuro.wustl.edu
Joel Perlmutter
- Recruiting
University of South Florida, HDSA Center of Excellence at USF
Tampa, Florida, 33612
Kelly Elliott, 813-974-6022, kelliot@usf.edu
Juan Sanchez-Ramos
- Recruiting
Georgetown University
Washington D.C., District of Columbia, 20007
Erin Koppel, 202-687-1525, ek875@georgetown.edu
Karen Anderson
- Recruiting
Hereditary Neurological Disease Center
Wichita, Kansas, 67226
Gregory Suter, 316-609-3020, hndcentre@aol.com
William Mallonee
- Recruiting
Wake Forest School of Medicine
Winston-Salem, North Carolina, 27157
Summer Harris, 336-716-3919, sdharris@wakehealth.edu
Jessica Tate
United Kingdom30 sites, 26 recruiting
- Recruiting
University of Aberdeen
Aberdeen, AB25 2ZA
Stella Sihlabela, +44 (0) 1224 550024, stella.sihlabela@nhs.scot
Zosia Miedzybrodzka
- Recruiting
Birmingham and Solihull Mental Health NHS Foundation Trust
Birmingham, B15 2FG
Elsa Benn, +44 (0)121 3014337, e.benn@nhs.net
Hugh Rickards
- Recruiting
North Bristol NHS Trust
Bristol, UK, BS10 5NB
Rebecca Pracownik, +44 (0)117 414 8194, rebecca.pracownik@nbt.nhs.uk
Elizabeth Coulthard
- Recruiting
University of Cambridge
Cambridge, CB2 0PY
Amy Evans, +44 (0)122 376 1863, ahe28@cam.ac.uk
Roger Barker
- Recruiting
Cardiff University
Cardiff, CF24 4HQ
Laura Mills, +44 (0)2920 687613, millslj@cardiff.ac.uk
Anne Rosser
- Recruiting
Tayside Health Board
Dundee, DD1 9SY
Paula Mcfadyen, +44 (0) 1382 424172, paula.mcfadyen@nhs.net
Jonathan Berg
- Recruiting
Lothian Health Board
Edinburgh, EH4 2XU
Maria Dewar, +44 (0) 1315 371116, maria.dewar@nhslothian.scot.nhs.uk
Peter Foley
- Recruiting
Royal Devon and Exeter NHS Foundation Trust
Exeter, Devon, EX25DW
Evanna McEvoy, +44 (0)139 240 6979, evanna.mcevoy@nhs.net
Timothy Harrower
- Recruiting
Greater Glasgow Health Board
Glasgow, G51 4TF
Helen Bannister, +44 (0)141 232 7600, helen.bannister@ggc.scot.nhs.uk
Stuart Ritchie
- Terminated
Ayrshire Central Hospital
Kilmarnock, KA2 OBB
- Recruiting
Fife Health Board
Kirkcaldy, UK, KY1 2ND
Nicola Johns, +44 (0) 1592 647993, nicola.johns@nhs.net
Simon Rubidge
- Terminated
NHS Forth Valley
Larbert, FK5 4WR
- Recruiting
Leeds Teaching Hospitals
Leeds, LS7 4SA
Callum Schofield, 0113 39 24679, callum.schofield@nhs.net
Alison Kraus
- Recruiting
The Walton Centre
Liverpool, L9 7LJ
Andrea Clyne, +44 01515563720, andrea.clyne@thewaltoncentre.nhs.uk
Rhys Davies
- Recruiting
Guy's and St. Thomas's NHS Foundation Trust
London, SE1 9RT
Elizabeth White, 02071887865, elizabeth.white@gstt.nhs.uk
Thomasin Andrews
- Recruiting
St. George's Hospital
London, SW17 0RE
Hae-Ree Seo, +44 (0)208 725 1971, haeree.seo@stgeorges.nhs.uk
Nayana Lahiri
- Recruiting
University College of London
London, WC1B SEH
Jessica Lowe, jessica.lowe@ucl.ac.uk
Sarah Tabrizi
- Recruiting
Central Manchester University Hospitals NHS Foundation Trust
Manchester, M13 9WL
Helen Chadwick, 0161 701 2541, helen.chadwick@mft.nhs.uk
David Craufurd
- Recruiting
Leicestershire Partnership
Narborough, Leicestershire, LE19 4SL
Iain Termie, iain.termie@leicspart.nhs.uk
Reza Kiana
- Recruiting
Northumberland, Tyne & Wear NHS Foundation Trust of St. Nicholas Hospital
Newcastle upon Tyne, NE3 3XT
Sarah Edwards, +01 (0)912 467 392, sarah.edwards@ntw.nhs.uk
Suresh Komati
- Terminated
St. Andrews Healthcare
Northampton, NN1 5DG
- Recruiting
Oxford Radcliffe Hospitals
Oxford, OX3 9DU
Zara Skitt, +44 (0)1865 234309, zara.skitt@ouh.nhs.uk
Andrea Nemeth
- Recruiting
Plymouth Hospitals NHS Trust
Plymouth, PL6 8BX
Charlotte Orr, +44 (0)1752 432845, charlotteorr@nhs.net
Rupert Noad
- Recruiting
Poole Hospital
Poole, BH15 2JB
Annemieke Fox, 0300 019 3210, annemieke.fox@poole.nhs.uk
John Burn
- Recruiting
Royal Berkshire NHS Foundation Trust
Reading, RG1 5AN
Zara Skitt, +44 (0)1865 234309, zara.skitt@ouh.nhs.uk
Richard Armstrong
- Recruiting
Sheffield Children's NHS Foundation Trust
Sheffield, S10 2TH
Pauline Bayliss, 0114 2260828, pauline.bayliss@sch.nhs.uk
Alisdair McNeill
- Recruiting
University Hospital Southampton
Southampton, SO16 6YD
Veena Agarwal, +44 (0)238 120 6132, veena.agarwal@uhs.nhs.uk
Christopher Kipps
- Recruiting
North Staffordshire Combined Healthcare NHS Trust
Stoke-on-Trent, ST4 8HH
Karen Kennedy, 01782 652675, karen.kennedy@northstaffs.nhs.uk
George El-Nimr
- Active, not recruiting
Avon and Wiltshire Mental Health Partnership
Swindon, SN3 6BW
- Recruiting
Betsi Cadwaladr University Health Board
Wrexham, UK, LL13 7TD
Julia Roberts, +44 (0)1248 383091, julia.roberts@bangor.ac.uk
Alberto Salmoiraghi
Germany14 sites, 13 recruiting
- Recruiting
University Hospital Aachen
Aachen, 52074
Rena Overbeck, +49 (0)241 803 7705, ronneken@ukaachen.de
Kathrin Reetz
- Recruiting
University of Berlin
Berlin, 10117
Stefanie Kehrer, 49(0)30450-617-276, stefanie.kehrer@charite.de
Josef Priller
- Recruiting
St. Josef und St. Elisabeth Hospital
Bochum, 44791
Barbara Kaminski, +49 (0)234 509 2703, b.kaminski@klinikum-bochum.de
Carsten Saft
- Recruiting
University Hospital Carl Gustav Carus Dresden
Dresden, 1307
Simone Kögler, 0049 351 4582524, simone.koegler@uniklinikum-dresden.de
Björn Falkenburger
- Recruiting
University Hospital Erlangen
Erlangen, 91054
Susanne Seifert, 0049 91318544751, susanne.seifert@uk-erlangen.de
Jürgen Winkler
- Recruiting
University Medical Center Freiburg
Freiburg im Breisgau, 79106
Gerit Kammel, +49 761 270 54750, gerit.kammel@uniklinik-freiburg.de
Michel Rijntjes
- Recruiting
Paracelsus Elena Klinik Kassel
Kassel, 34128
Grit Langhans, 0049 561 6009 - 169, grit.langhans@paracelsus-kliniken.de
Claudia Trenkwalder
- Recruiting
University Hospital Schleswig-Holstein
Lübeck, 23538
Jenny Schmalfeld, +49 451 3101 8214, jenny.schmalfeld@neuro.uni-luebeck.de
Alexander Münchau
- Terminated
University Hospital Giessen and Marburg
Marburg, 25043
- Recruiting
Technical University of Munich
Munich, 81675
Antje Lüsebrink, +49 89 4140 4693, antje.luesebrink@tum.de
Adolf Weindl
- Recruiting
George-Huntington-Institut GmbH
Münster, 48149
Anja Kletsch, +49 251 7887880, anja.kletsch@ghi-muenster.de
Ralf Reilmann
- Recruiting
kbo-Isar-Amper-Klinikum Taufkirchen (Vils)
Taufkirchen, 84416
Michael Bachmaier, +49 (0)808 493 4417, michael.bachmaier@kbo.de
Alzbeta Mühlbäck
- Recruiting
University Hopsital of Ulm
Ulm, 89081
Hela Jerbi, +49 731 50063080, ambulanz-ulm@euro-hd.net
Bernhard Landwehrmeyer
- Recruiting
University Hospital of Wuerzburg
Würzburg, 97080
Christine Leypold, +49 931 201 23510, leypold_c@ukw.de
Thorsten Odorfer
Spain12 sites, 12 recruiting
- Recruiting
Hospital Infanta Cristina, Badajoz
Badajoz, 06080
Patrocinio García Moreno, +34 (0)637 566 300, patrocinio.garciam@externos.salud-juntaex.es
Carmen Durán Herrera
- Recruiting
Hospital de Cruces
Barakaldo, 08036
Maria Angeles Acera Gill, +34 (0)946 006 363, m.angeles.aceragil@osakidetza.net
Juan Carlos Gómez Esteban
- Recruiting
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025
Andrea Horta, +34 (0)935 567 253, ahorta@santpau.cat
Jaime Kulisevsky
- Recruiting
Hospital Mare de Déu de la Mercè
Barcelona, 08035
Patricia Vaquero Casado, 0034934185826, pvaqueroc.merced@hospitalarias.es
Jesus Ruíz Idiago
- Recruiting
Fundacion Clinic per a La Recerca Biomèdica
Barcelona, 08036
Pilar Santacruz, +34 (0)932 275 4003 088, psanta@clinic.cat
Esteban Muñoz
- Recruiting
Hospital Universitari de Bellvitge
Barcelona, 08907
Serge Jaumà Classen, 34 93 335 70 11
Matilde Calopa Garriga
- Recruiting
Hospital Universitario de Burgos
Burgos, 09006
Natividad Mariscal, +34 (0)947 256 533, namariscal@saludcastillayleon.es
Esther Cubo
- Recruiting
Hospital Universitario Ramón y Cajal
Madrid, 28034
Monica Aguilar, monicaaguilar.hrc@gmail.com
José Luis López-Sendón Moreno
- Recruiting
Fundación Jiménez Díaz
Madrid, 28040
Noelia Rodríguez Martínez, +34 (0)689 463 417, noe-rodriguez@hotmail.com
María Teresa Montojo
- Recruiting
Hospital Son Espases
Palma de Mallorca, 07120
Mónica Rodríguez, +34 (0)658 886 467, psicologa.huntington@gmail.com
Ines Legarda
- Recruiting
Complejo Hospitalario de Navarra
Pamplona, 31008
Ana Carmona Rueda, +34 (0)848 429 990, anacarmonarueda@gmail.com
María Ramos
- Recruiting
Fundacion Hospital Universitario La Fe
Valencia, 46970
Francisco Casterá Brugada, +34 (0)645 134 892, franciscocasteraenroll@gmail.com
Carmen Peiró
France11 sites, 11 recruiting
- Recruiting
CHU Amiens-Picardie
Amiens, 80054
Stéphanie Blin, +33(0)3 22 66 80 00 ext. 63206, blin.stephanie@chu-amiens.fr
Pierre Krystkowiak
- Recruiting
CHU Angers, Centre de Référence Maladies Neurogénétiques
Angers, 49100
Audrey Olivier, +33 (0)241 355 615, AuOlivier@chu-angers.fr
Christophe Verny
- Recruiting
Bordeaux - Huntington Disease competencies center
Bordeaux, 33076
Marie-Pierre Baudier, +33 (0)149 814 301, marie-pierre.baudier@chu-bordeaux.fr
Cyril Goizet
- Recruiting
CHU Gabriel-Montpied
Clermont-Ferrand, 63003
Dihya Benghadid, +33 (0)473 754 067, dbenghadid@chu-clermontferrand.fr
Ana Marques
- Recruiting
Hôpital Henri Mondor, Centre d'Investigation Clinique
Créteil, 94000
Graça Morgado, +33 (0)149 814 301, graca.morgado@aphp.fr
Anne-Catherine Bachoud-Levi
- Recruiting
Lille-Amiens - Huntington Disease Constituent site
Lille, 59037
Eric Decorte, +33 (0)3.20.44.59.62 ext. 30583, eric.decorte@chru-lille.fr
Mélissa Tir
- Recruiting
Hôpital La Timone
Marseille, 13005
Laura Mundler, +33 (0)491 384 872, laura.mundler@ap-hm.fr
Jean-Philippe Azulay
- Recruiting
CHU Montpellier
Montpellier, 34295
Diana Ban, +33 (0)777 308 857, d-ban@chu-montpellier.fr
Cecilia Marelli
- Recruiting
Institut du Cerveau et de la Moelle Epinière
Paris, 75646
Hortense Hurmic, +33 (0)157 274 222, hortense.hurmic@icm-institute.org
Alexandra Durr
- Recruiting
Hôpitaux Universitaires de Strasbourg Hôpital de Hautepierre-Service de Neurologie
Strasbourg, Alsace Lorraine, 67098
Fanny Huselstein, +33 (0)388 128 642, fanny.huselstein@chru-strasbourg.fr
Christine Tranchant
- Recruiting
Hôpital Purpan, Centre d'Investigation Clinique
Toulouse, 31059
Brigitte Pouzet, +33 (0)561 779 125, brigitte.pouzet@inserm.fr
Fabienne Calvas
Canada9 sites, 7 recruiting
- Recruiting
University of Calgary, Movement Disorders Program
Calgary, Alberta, T2N 4N1
Lorelei Tainsh, (403) 210-9873, derwent@ucalgary.ca
Justyna Sarna
- Terminated
University of Alberta (Glenrose)
Edmonton, Alberta, T5G 0B7
- Recruiting
University of Alberta Hospital in Edmonton
Edmonton, Alberta, T6G 2B7
Vanessa Larida, 780-248-1157, larida@ualberta.ca
Oksana Suchowersky
- Recruiting
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 3A7
Patrick Bethune, 902-431-8783, patrick.bethune@centricityresearch.com
Kerrie Schoffer
- Terminated
Centre for Movement Disorders
Markham, Ontario, L6B 1C9
- Recruiting
CHUM Hospital of Notre Dame
Montreal, Quebec, H2L 4M1
Lyne Jean, 514.890.8000 ext. 26470, lyne.jean.chum@ssss.gouv.qc.ca
Sylvain Chouinard
- Recruiting
The Ottawa Hospital
Ottawa, Ontario, K1Y 4E9
Jane Ding, (613) 798-5555, jading@toh.ca
Tiago Mestre
- Recruiting
North York General Hospital
Toronto, Ontario, M2K 1E2
Clare Gibbons, 416 756 6788, clare.gibbons@nygh.on.ca
Alan Fung
- Recruiting
University of British Columbia
Vancouver, British Columbia, V6T 2B5
Mike Adurogbangba, 604-822-4872, madurogbangba@cmmt.ubc.ca
Lynn Raymond
Italy9 sites, 8 recruiting
- Recruiting
Bari Policlinico General Hospital
Bari, 70124
Vittorio Sciruicchio, +39 3391032862, vsciru@tin.it
Marina de Tommaso
- Recruiting
IRCCS Istituto delle Scienze Neurologiche di Bologna
Bologna, 40139
Cesa Scaglione, +39 0514966919, cesa.scaglione@unibo.it
Pietro Cortelli
- Recruiting
Università degli Studi di Genova (DINOGMI)
Genoa, 16132
Roberta Marchese, +39 0103538968, rmarchese@neurologia.unige.it
Paola Mandich
- Recruiting
Fondazione IRCCS Istituto Neurologico Carlo Besta - Genetics
Milan, MI, 20133
Lorenzo Nanetti, 0039 02 23942519, lorenzo.nanetti@istituto-besta.it
Caterina Mariotti
- Terminated
Fondazione IRCCS Istituto Neurologico Carlo Besta - Neurology
Milan, 20133
- Recruiting
University of Naples
Naples, I-80131
Elena Salvatore, +39 3356096228, e.salvatore@unina.it
Giuseppe De Michele
- Recruiting
Università Cattolica del Sacro Cuore
Rome, 00168
Flavia Torlizzi, +39 338.8069142, flavia.torlizzi@policlinicogemelli.it
Anna Rita Bentivoglio
- Recruiting
Lega Italiana Ricerca Huntington (LIRH)
Rome, 00185
Barbara D'Alessio, +39 3272870465, barbara.dalessio@lirh.it
Ferdinando Squitieri
- Recruiting
Azienda Ospedaliera Sant'Andrea
Rome, 00189
Silvia Romano, +39 0633776044, silvia.romano@uniroma1.it
Giovanni Ristori
Poland6 sites, 4 recruiting
- Recruiting
Copernicus Podmiotem Leczniczym sp. z o.o.
Gdansk, 80-462
Ewa Narożańska, +48 (0)512 384 610, gdansk.ewa1@gmail.com
Witold Soltan
- Recruiting
Krakowska Akademia Neurologii Sp. z o.o
Katowice, 40-588
Agnieszka Prymus, +48 (0)505 723 735, agnieszkamarcin@o2.pl
Monika Rudzińska-Bar
- Recruiting
Krakow - Krakowska Akademia Neurologii
Krakow, 31-505
Marta Pinkosz, 48,663,506,020, marta.pinkosz@neurologia.org.pl
Monika Rudzińska-Bar
- Terminated
Solumed Centrum Medyczne
Poznan, 60-529
- Terminated
Medical University of Warsaw
Warsaw, 02-097
- Recruiting
Institute of Psychiatry and Neurology, Warsaw
Warsaw, 02-957
Karolina Ziora-Jakutowicz, +48 (0)690 831 022, jakutowicz@ipin.edu.pl
Grzegorz Witkowski
Portugal5 sites, 4 recruiting
- Recruiting
Hospital Prof Doutor Fernando Fonseca
Amadora, 2720-276
Helena Cardoso, +351 214348269, helenamcard26@gmail.com
Cristina Costa, MD
- Not yet recruiting
Hospital Universitário de Coimbra
Coimbra, 3000-075
Cristina Januário, +351 239 400 400
Cristina Januário
- Terminated
Central Lisbon Hospital
Lisbon, 1169-050
- Recruiting
Hospital de Santa Maria / Instituto de Medicina Molecular
Lisbon, 1649-035
Tânia Silva, 00 351 217930629, cicneuro.lisbon@gmail.com
Leonor Correia Guedes
- Not yet recruiting
Hospital Universitário de São João
Porto, 4200-319
Ana Oliveira, +351 225 512 100 ext. 5119
Leonor C Guedes
Australia4 sites, 4 recruiting
- Recruiting
Monash University
Melbourne, Victoria, 3800
Emma Windebank, +61 03 9834 9430, emma.windebank@calvarycare.org.au
Ruth Krasniqi, +61 3 9595 3288, ruth.krasniqi@calvarycare.org.au
- Recruiting
University of Melbourne, Royal Melbourne Hospital
Parkville, 3052
Joanna Neath, 613 8387 2483, joanna.neath@mh.org.au
Anita Goh
- Recruiting
The Neurosciences Unit - North Metropolitan Hospital
Perth, Western Australia, 6010
Melanie Clark, 00643 3786078, melanie.clark@health.wa.gov.au
Brian Long
- Recruiting
Westmead Hospital
Westmead, New South Wales, 2145
Therese Alting, +02 (0)984 563 10, therese.alting@health.nsw.gov.au
Clement Loy
Belgium4 sites, 4 recruiting
- Recruiting
Bruxelles - Erasme
Brussels, 1070
Nick Alaerts, +32 (0)255 558 74, nick.alaerts@erasme.ulb.ac.be
Frédéric Supiot
- Recruiting
Institut de Pathologie et de Génétique (IPG)
Charleroi, B-6041
Cécile Minet, +32 (0)714 471 30, cecile.minet@ipg.be
Christine Verellen-Dumoulin
- Recruiting
University Hospitals Leuven
Leuven, Vlaams-Brabant, 3000
Ann-Julie Trippas, +32 16 34 64 51, ann-julie.trippas@uzleuven.be
Wim Vandenberghe
- Recruiting
Hôpital du Beau Vallon ASBL
Saint-Servais, B-5002
Jean-Marie Warzee, +32 (0)817 212 41, jm.warzee@beauvallon.be
Lamia Guettat
Denmark3 sites, 3 recruiting
- Recruiting
University Hospital of Aarhus
Aarhus, 8000
Charlotte Germann Odgaard, +4521745502, charodga@rm.dk
Anette Torvin Møller
- Recruiting
University Hospital of Copenhagen
Copenhagen, DK2100
Christina Vangsted Hansen, +4535458293, christina.vangsted.hansen@regionh.dk
Lena E Hjermind
- Recruiting
University Hospital of Odense
Odense, 5000
Stinne Veilstrup Krøigård, +4524671929, stinne.veilstrup@rsyd.dk
Morten Blaabjerg
Netherlands3 sites, 3 recruiting
- Recruiting
University Medical Center Groningen
Groningen, 9700RB
Maraike Coenen, +31 503619727, m.a.coenen@umcg.nl
H.P.H. Kremer
- Recruiting
Leiden University Medical Centre
Leiden, 2300 RC
Esther Arendts, 31715261218, e.c.arendts@lumc.nl
Susanne de Bot
- Recruiting
Clinical Trial Center Maastricht B.V.
Maastricht, 6202 AZ
Daisy Ramakers, +31(0)43-3877676, daisy.ramakers@mumc.nl
Mayke Oosterloo
New Zealand3 sites, 3 recruiting
- Recruiting
Auckland City Hospital
Auckland, 1142
Christina Buchanan, 093074949 ext. 25747, cbuchanan@adhb.govt.nz
Richard Roxburgh
- Recruiting
New Zealand Brain Research Institute at University of Otago
Christchurch, 8011
Laura Paermentier, +64 03 364 0825 ext. 80825, laura.paermentier@cdhb.health.nz
Tim Anderson
- Recruiting
Wellington Hospital
Wellington, 6021
Grace Hodgson, +64 4 806 0078, Grace.Hodgson@ccdhb.org.nz
David Bourke
Colombia2 sites, 2 recruiting
- Recruiting
Servicios Médicos MS, Clínica de Marly
Bogotá, Cundinamarca, 110231
Natalia Velez, (+573) 153 611090, nvelezmd@gmail.com
Gabriel Jose Arango Uribe
- Recruiting
Universidad de Antioquia, Grupo de Neurociencias
Medellín, Antioquia, 51922
Sonia Moreno, (+574) 219 6424, sonia.moreno@gna.org.co
Francisco Lopera
Switzerland2 sites, 2 recruiting
- Recruiting
Siloah AG
Gümligen, 3073
Jessica Köhli, 0041 31 352 20 70, jessica.koehli@siloah.ch
Jean-Marc Burgunder
- Recruiting
University Hospital Zurich
Zurich, 08091
Maike Heider, +41 44 255 55 20, maike.heider@usz.ch
Hans Jung
Argentina1 site, 1 recruiting
- Recruiting
Instituto de Neurociencias Buenos Aires (INEBA)
Buenos Aires
Maria Lucrecia Pavon, +(54) 9 11 6008 9846, mpavon@ineba.net
L
Austria1 site, 1 recruiting
- Recruiting
Universitatsklinik Innsbruck
Innsbruck, 6020
Anja Weber, +43 512-504-83716, anja.weber@tirol-kliniken.at
Klaus Seppi
Chile1 site, 1 recruiting
- Recruiting
CETRAM
Santiago
Natalia Rojas, +(569) 73997271, nrojas@cetram.org
Pedro Chana
Ireland1 site, 1 recruiting
- Recruiting
Beaumont Hospital
Dublin, Republic of Ireland
Mairead Fallon, +00 (0)353 018 0920 ext. 18, maireadfallon@beaumont.ie
Niall Pender
About this study
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and biomarkers for progression and prognosis, identifying clinically-relevant phenotypic characteristics, and establishing clearly defined endpoints for interventional studies. Periodic cuts of the database are now available to any interested researcher to use in their research - visit www.enroll-hd.org/for-researchers/access-data/ to learn more.
Read the detailed description
The primary objective of Enroll-HD is to develop a comprehensive repository of prospective and systematically collected clinical research data (demography, clinical features, family history, genetic characteristics) and biological specimens (blood) from individuals with manifest HD, unaffected individuals known to carry the HD mutation or at risk of carrying the HD mutation, and control research participants (e.g., spouses, siblings or offspring of HD mutation carriers known not to carry the HD mutation). Enroll-HD is conceived as a broad-based and long-term project to maximize the efficiencies of non-clinical research and participation in clinical research. With more than 150 active clinical sites in 23 countries, Enroll-HD is now the largest HD database available and is accessible to any interested researcher - visit www.enroll-hd.org/for-researchers/access-data/ to learn more.
- Conditions
- Huntington's Disease
- Keywords
- Huntington's Disease, Huntington Disease, Juvenile Huntington's Disease, Registry, Cohort, CHDI
- Medical subject headings
- Huntington Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
Motor Assessments: Unified Huntington's Disease Rating Scale (UHDRS) 99 Motor, UHDRS '99 Diagnostic Confidence Level
The motor section of the UHDRS assesses motor features of HD with standardized ratings of oculomotor function, dysarthria, chorea, dystonia, gait, and postural stability. UHDRS 99 Motor, UHDRS Diagnostic Confidence Level.
Measured: through study completion, an average of 1 year
Functional Assessments: UHDRS '99 Total Functional Capacity, UHDRS '99 Functional Assessment Scale, UHDRS '99 Independence Scale
The Total Functional Capacity, Functional Assessment and Independence Subscales of the UHDRS '99 will be used to assess participants' functional status. The Total Functional Capacity scale has established psychometric properties including inter-rater reliability and validity, based on radiographic measures of disease progression.
Measured: through study completion, an average of 1 year
Problem Behaviors Assessment-Short (PBA-s)
The Problem Behavioral Assessment Short Version (PBA-s) will be used to perform behavioral assessments. This instrument measures frequency and severity of symptoms related to altered affect, thought content and coping styles.
Measured: through study completion, an average of 1 year
Cognitive Assessments: Symbol Digit Modality Test; Stroop Color Naming; Stroop Word Reading; Categorical Verbal Fluency
Cognition will be assessed using the Categorical Verbal Fluency Test, Symbol Digit Modality Test and Stroop Color and Word Reading Test. Verbal fluency is a commonly used neuropsychological test which examines the ability to spontaneously produce words orally within a fixed time span. For category fluency, words must be produced according to semantic constraints. The measure of performance used will be the number of correctly generated words within 60 seconds.
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Apr 2012 (estimated)
- Study startJul 2012
- Primary completionJan 2062 (estimated)
- Study completionJan 2062 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Huntington's DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 35,000 participants (estimated)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- CHDI Foundation, Inc.
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Bernhard G Landwehrmeyer, MD, PhD, Principal investigator, University of UlmJamie Levey, Study director, CHDI Foundation, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01574053
- Sponsor's protocol ID
- Enroll -HD
- Status last verified
- Feb 2024
- First submitted
- 6 Apr 2012
- Last updated
- 28 Feb 2024
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Gray SM, Dai J, Smith AC, Beckley JT, Rahmati N, Lewis MC, Quirk MC. Changes in 24(S)-Hydroxycholesterol Are Associated with Cognitive Performance in Early Huntington's Disease: Data from the TRACK and ENROLL HD Cohorts. J Huntingtons Dis. 2024 Nov;13(4):449-465. doi: 10.3233/JHD-240030.
PubMed 39269850Langbehn DR, Sathe SS, Loy C, Sampaio C, Mccusker EA. A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study. Neurol Genet. 2023 Nov 28;9(6):e200111. doi: 10.1212/NXG.0000000000200111. eCollection 2023 Dec.
PubMed 38035176Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, Goncalves N, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C. Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease. Mov Disord Clin Pract. 2016 Jun 22;4(2):212-224. doi: 10.1002/mdc3.12388. eCollection 2017 Mar-Apr.
PubMed 30363395
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- ClinicalTrials.gov ID
- NCT01574053
- Acronym / sponsor ID
- Enroll -HD
- Conditions
- Huntington's Disease
- Keywords
- Huntington's Disease, Huntington Disease, Juvenile Huntington's Disease, Registry, Cohort, CHDI
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 35,000 participants (estimated)
- Lead sponsor
- CHDI Foundation, Inc.University, hospital or other
- Study start
- Jul 2012 (actual)
- Primary completion
- Jan 2062 (estimated)
- Study completion
- Jan 2062 (estimated)
- First posted
- 10 Apr 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and biomarkers for progression and prognosis, identifying clinically-relevant phenotypic characteristics, and establishing clearly defined endpoints for interventional studies. Periodic cuts of the database are now available to any interested researcher to use in their research - visit www.enroll-hd.org/for-researchers/access-data/ to learn more.
Detailed description
The primary objective of Enroll-HD is to develop a comprehensive repository of prospective and systematically collected clinical research data (demography, clinical features, family history, genetic characteristics) and biological specimens (blood) from individuals with manifest HD, unaffected individuals known to carry the HD mutation or at risk of carrying the HD mutation, and control research participants (e.g., spouses, siblings or offspring of HD mutation carriers known not to carry the HD mutation). Enroll-HD is conceived as a broad-based and long-term project to maximize the efficiencies of non-clinical research and participation in clinical research. With more than 150 active clinical sites in 23 countries, Enroll-HD is now the largest HD database available and is accessible to any interested researcher - visit www.enroll-hd.org/for-researchers/access-data/ to learn more.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with HD and their family members are recruited from specialty clinics (Human Genetics, Neurology, Psychiatry) that advise and treat people affected by HD. In addition, in some areas community clinics and neurologists who see HD patients recruit participants for this study. Participants also receive information about the study through websites, clinical practices, support groups, advocacy newsletters, etc. and place a direct request to be considered for participation in the study. Community controls are identified by study site staff (using advertisements, flyers and newsletters) with the support of the Enroll-HD operational staff.
Key inclusion criteria (10 listed)
- Carriers: This group comprises the primary study population and consists of individuals who carry the HD gene expansion mutation.
- Controls: This group comprises the comparator study population and consists of individuals who do not carry the HD expansion mutation.
- These two major categories can be further subdivided into six different subgroups of eligible individuals:
- Manifest/Motor-manifest HD: Carriers with clinical features that are regarded in the opinion of the investigator as diagnostic of HD.
- Pre-Manifest/-Motor-manifest HD: Carriers without clinical features regarded as diagnostic of HD.
Key exclusion criteria (4 listed)
- Individuals who do not meet inclusion criteria,
- Individuals with choreic movement disorders in the context of a negative test for the HD gene mutation.
- For Community Controls: those individuals with a major central nervous system disorder will be excluded (e.g. stroke, Parkinson's disease, multiple sclerosis, etc.).
- Participants under 18 may be eligible to participate (if they have juvenile-onset HD).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Motor Assessments: Unified Huntington's Disease Rating Scale (UHDRS) 99 Motor, UHDRS '99 Diagnostic Confidence Level
Time frame: through study completion, an average of 1 year
The motor section of the UHDRS assesses motor features of HD with standardized ratings of oculomotor function, dysarthria, chorea, dystonia, gait, and postural stability. UHDRS 99 Motor, UHDRS Diagnostic Confidence Level.
Functional Assessments: UHDRS '99 Total Functional Capacity, UHDRS '99 Functional Assessment Scale, UHDRS '99 Independence Scale
Time frame: through study completion, an average of 1 year
The Total Functional Capacity, Functional Assessment and Independence Subscales of the UHDRS '99 will be used to assess participants' functional status. The Total Functional Capacity scale has established psychometric properties including inter-rater reliability and validity, based on radiographic measures of disease progression.
Problem Behaviors Assessment-Short (PBA-s)
Time frame: through study completion, an average of 1 year
The Problem Behavioral Assessment Short Version (PBA-s) will be used to perform behavioral assessments. This instrument measures frequency and severity of symptoms related to altered affect, thought content and coping styles.
Cognitive Assessments: Symbol Digit Modality Test; Stroop Color Naming; Stroop Word Reading; Categorical Verbal Fluency
Time frame: through study completion, an average of 1 year
Cognition will be assessed using the Categorical Verbal Fluency Test, Symbol Digit Modality Test and Stroop Color and Word Reading Test. Verbal fluency is a commonly used neuropsychological test which examines the ability to spontaneously produce words orally within a fixed time span. For category fluency, words must be produced according to semantic constraints. The measure of performance used will be the number of correctly generated words within 60 seconds.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2024.
- Derived from this study: PubMed 39269850Gray SM, Dai J, Smith AC, Beckley JT, Rahmati N, Lewis MC, Quirk MC. Changes in 24(S)-Hydroxycholesterol Are Associated with Cognitive Performance in Early Huntington's Disease: Data from the TRACK and ENROLL HD Cohorts. J Huntingtons Dis. 2024 Nov;13(4):449-465. doi: 10.3233/JHD-240030.
- Derived from this study: PubMed 38035176Langbehn DR, Sathe SS, Loy C, Sampaio C, Mccusker EA. A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study. Neurol Genet. 2023 Nov 28;9(6):e200111. doi: 10.1212/NXG.0000000000200111. eCollection 2023 Dec.
- Derived from this study: PubMed 30363395Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, Goncalves N, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C. Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease. Mov Disord Clin Pract. 2016 Jun 22;4(2):212-224. doi: 10.1002/mdc3.12388. eCollection 2017 Mar-Apr.
Related trials for Huntington's Disease
Recruiting
Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
Caregivers
RecruitingObservational study
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease
RecruitingPhase 1
A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Huntington's Disease
RecruitingPhase 3
Pridopidine Phase 3 Study in Huntington's Disease
Huntington Disease
RecruitingPhase 2/3
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Huntington Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Noopur Modi contact
Bernhard G Landwehrmeyer, MD, PhD principal investigator
University of Ulm
Jamie Levey study director
CHDI Foundation, Inc.
183 sites in 20 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Huntington's Disease, run by CHDI Foundation, Inc. at 183 sites in 20 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 183 sites in United States, United Kingdom, Germany, Spain, France and 15 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Noopur Modi (Info@Enroll-HD.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Motor Assessments: Unified Huntington's Disease Rating Scale (UHDRS) 99 Motor, UHDRS '99 Diagnostic Confidence Level (time frame: through study completion, an average of 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01574053, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.